Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy
Authors:
- Juan F. Navarro-GonzálezJNJuan F. Navarro-González
- Ana JarqueAJAna Jarque
- Mercedes MurosMMMercedes Muros
- Carmen MoraCMCarmen Mora
- Javier GarcíaJGJavier García
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 20 (2) , 165-173
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-α stimulation, and effects of a phosphodiesterase inhibitorLife Sciences, 2007
- Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cellsKidney International, 2004
- Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathyKidney International, 2001
- Pentoxifylline in Management of Proteinuria in Diabetic NephropathyNephron, 1993
- Tumor necrosis factor alpha and mesangial cellsKidney International, 1992
- Interleukin 1 and tumor necrosis factor potentiate angiotensin II- and calcium ionophore-stimulated prostaglandin E2 synthesis in rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1990
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.Journal of Experimental Medicine, 1989
- Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1989
- PentoxifyllineDrugs, 1987